Accu-Break Pharmaceuticals

company

About

Accu-Break develops pharmaceutical tablet technologies to create tablets that can be easily divided by hand into exact smaller doses.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$5.65M
Industries
Biotechnology,Information Technology,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active

ACCU-BREAK Pharmaceuticals, Inc. develops and licenses pharmaceutical tablet technologies. The company offers bi-layer and tri-layer technologies, which are used to create tablets that are dividable by hand into accurate partial/smaller doses for patients to adjust their dose. Its technologies are used for single drug products, fixed and split combination drug products, standard and controlled release formulations, and incompatible drugs in human and veterinary medicines. The company has a strategic alliance agreement with Azopharma Development Group. ACCU-BREAK Pharmaceuticals, Inc. was formerly known as SoLapharm, Inc. and changed its name to ACCU-BREAK Pharmaceuticals, Inc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.65M
Accu-Break Pharmaceuticals has raised a total of $5.65M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2007 Series Unknown $5.65M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Accu-Break Pharmaceuticals is funded by 1 investors. S.A.C Capital Associates are the most recent investors.
Investor Name Lead Investor Funding Round
S.A.C Capital Associates Series Unknown